Pfizer (Germany) Analysis

PFE Stock   24.48  0.07  0.29%   
Pfizer Inc is fairly valued with Real Value of 24.94 and Hype Value of 24.48. The main objective of Pfizer stock analysis is to determine its intrinsic value, which is an estimate of what Pfizer Inc is worth, separate from its market price. There are two main types of Pfizer's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Pfizer's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Pfizer's stock to identify patterns and trends that may indicate its future price movements.
The Pfizer stock is traded in Germany on XETRA Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Pfizer is usually not traded on GermanUnityDay, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, International Workers ' Day. Pfizer Stock trading window is adjusted to Europe/Berlin timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Pfizer Stock Analysis Notes

About 71.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 17.03. The company has Price/Earnings To Growth (PEG) ratio of 1.19. Pfizer Inc recorded earning per share (EPS) of 5.08. The entity last dividend was issued on the 26th of January 2023. The firm had 100150:333 split on the 1st of July 1999. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.

Pfizer Inc Investment Alerts

Pfizer Inc generated a negative expected return over the last 90 days
About 71.0% of the company shares are owned by institutional investors

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 214.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

Pfizer's profitability indicators refer to fundamental financial ratios that showcase Pfizer's ability to generate income relative to its revenue or operating costs. If, let's say, Pfizer is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pfizer's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pfizer's profitability requires more research than a typical breakdown of Pfizer's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.39 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.39.

Technical Drivers

As of the 28th of November, Pfizer holds the Variance of 2.37, risk adjusted performance of (0.01), and Coefficient Of Variation of (5,637). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them.

Pfizer Inc Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pfizer middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pfizer Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Pfizer Outstanding Bonds

Pfizer issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pfizer Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pfizer bonds can be classified according to their maturity, which is the date when Pfizer Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pfizer Predictive Daily Indicators

Pfizer intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pfizer stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pfizer Forecast Models

Pfizer's time-series forecasting models are one of many Pfizer's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Pfizer to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Additional Tools for Pfizer Stock Analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.